Intro Stenabolic (sr9009) is a research drug that is an agonist of Rev-ERbA, meaning it increases the repression of genes it regulates. Although popularly sold as a SARM (selective androgen receptor agonist), it is actually...
Intro Anabolicum (LGD-4033) is a SARM (selective androgen receptor modulator) that is currently in preclinical trials by Ligand Pharmaceuticals. Hence the nickname Ligandrol. The hope is that it will one day replicate...
No More Results